Patients new to GLP-1 therapy, those with a history of nausea or gastrointestinal sensitivity, and individuals seeking to minimize initial side effects are ideal candidates for microdosing
This has less to do with storage temperature and more to do with contamination prevention, but it extends the safe-use window of your vial
Finally, well address some common myths and misunderstandings about potassium levels and semaglutide
Whilst it has a different mechanism to GLP-1 receptor agonists, it can be used in patients with high cholesterol and may be appropriate for those who cannot tolerate or access injectable treatments
The approval, Novo Nordisk said, makes Wegovy the first therapy approved in the United States to help people manage their weight and reduce heart disease risk
If needed, they may order a metabolic lab test to better understand your hormone and metabolic health or support insurance coverage